Intervention not reported
Leukopaenia (safety population) · women with metastatic triple‐negative breast cancer (mTNBC)
The intervention probably leads to higher leukopaenia (safety population) (moderate certainty).
1 finding from 1 review
Intervention not reported
Hospital length of stay (patients recovering from orthopaedic surgery) · patients recovering from surgery who otherwise would require acute hospital inpatient care
The intervention showed no clear difference in hospital length of stay (patients recovering from orthopaedic surgery) (moderate certainty).
1 finding from 1 review
Number of participants who needed orthopaedic surgery (not measured) · Paget's disease of bone
1 finding from 1 review
Number of participants who needed orthopaedic surgery (not measured) · Paget's disease of bone
1 finding from 1 review
Mortality in paediatric population (subgroup) · critically ill participants with ALI and ARDS
INO showed no clear difference in mortality in paediatric population (subgroup) compared with control group (moderate certainty).
1 finding from 1 review
RR 0.78 [0.51, 1.18]
185 participants
Moderate
Asthma symptoms · children with acute asthma
1 finding from 1 review
Blood loss in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Red cell transfusion requirement in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Intervention not reported
Severe thrombocytopaenia11 · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes severe thrombocytopaenia11 (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life1 Paediatric Asthma Quality of Life Questionnaire (PAQLQ). Scale from: 1 (worse) to 7 (better). · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Intervention not reported
Vancomycin versus teicoplanin (paediatric cardiac surgery) · surgical patients
1 finding from 1 review
Intervention not reported
Vancomycin versus teicoplanin (paediatric cardiac surgery) · surgical patients
1 finding from 1 review
Time to recovery/time to clinical stability ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Change in the severity status of bronchiolitis Assessed using a variety of scales · infants up to 24 months of age with acute bronchiolitis
Slow passive expiration showed no clear difference in change in the severity status of bronchiolitis Assessed using a… compared with control (low certainty).
1 finding from 1 review
Adverse events ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Time to recovery/time to clinical stability ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Change in the severity status of bronchiolitis Assessed using a variety of scales · infants up to 24 months of age with acute bronchiolitis
It is very uncertain whether forced expiration changes change in the severity status of bronchiolitis Assessed using a… compared with control (very low certainty).
1 finding from 1 review
Adverse events ( · infants up to 24 months of age with acute bronchiolitis
Forced expiration leads to higher adverse events ( compared with control (high certainty).
1 finding from 1 review
Treatment failure · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Adverse drug reactions · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drug reactions compared with inpatients ‐ children (low certainty).
1 finding from 1 review